EWSR1 and cancer: Combining the action of OVs with other immunotherapeutic approaches, such as immune checkpoint inhibitors or chimeric antigen receptor (CAR)-T cells is gaining traction in the treatment of other cancer types and may be an important consideration in OV therapy for EWS [64].